|
|
|
13.08.25 - 23:18
|
Cresco Labs Closes $325 Million Senior Secured Term Loan Refinancing (Business Wire)
|
|
|
Transaction Extends Maturity to 2030, Strengthens Balance Sheet and Positions Company for GrowthCHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the closing of its previously announced refinancing of the Company's senior secured credit facility.
The new US$325 million senior secured term loan bears an interest rate of 12.5% per annum and matures on August 13, 2030. It replaces the Company's prior US$360 million facility, reducing total debt, extending the maturity to 2030, and providing enhanced flexibility to prepay up to US$125 million at a reduced premium.
“This transaction is another milestone in our disciplined approach to capital management,” said Charlie Bachtell, CEO of Cresco Labs. “We have strengthened our balance sheet and removed near-term refinancing risk. With this foundation in place, we can remain focused on executing our growth strategy.”
Proceeds from the new facility, together with cash on ...
|
|
|
|
|
|
|
07.08.25 - 12:33
|
Cresco Labs Solid Q2 Performance and Debt Refinancing Strengthen Foundation for Long-Term Value Creation (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the second quarter ended June 30, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here.
Second Quarter 2025 Highlights
Second quarter revenue of $164 million. Second quarter operating cash flow of $9 million.
Gross profit of $83 million. Adjusted gross profit1 of $83 million; and an Adjusted gross margin1 of 50.6% of revenue.
SG&A of $51 million or 31.4% of revenue.
Net loss of $14 million, includes non-cash impairment charges of $9 million related to California assets being considered held for sale.
Second quarter Adjusted EBITDA1 of $41 ...
|
|
|
06.08.25 - 22:36
|
Cresco Labs Announces Commitments to Refinance its Senior Secured Credit Facility (Business Wire)
|
|
|
Will Reduce Debt and Reinforces Commitment to Prudent Capital ManagementCHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced that it has successfully obtained commitments to refinance its senior secured credit facility (the “Senior Loan”).
The refinancing, upon closing, will provide for a new senior secured term loan totaling US$325 million, bearing an interest rate of 12.5% per annum, and maturing on the 5th year anniversary of the closing of the refinancing. The new facility will replace the Company's existing US$360 million credit facility, providing enhanced financial flexibility and favorable terms, including provisions that will allow for the prepayment of up to US$125 million at a reduced prepayment premium.
The refinancing comes at a time when access to capital remains highly constrained across the U.S. cannabis sector. With an estimated $2 billion in industry debt maturities coming due over the next 18 months...
|
|
|
17.07.25 - 12:36
|
Cresco Labs to Report Second Quarter 2025 Financial Results on August 7, 2025 (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the second quarter ended June 30th, 2025 on Thursday, August 7, 2025 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs Second Quarter 2025 Earnings Conference Call
Date: Thursday, August 7, 2025
Time: 8:30 am ET
Webcast: LINKConference Call Registration: LINKDial-in: 1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)
Access Code: 158138
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG approach to...
|
|
|
|
|
|
|
|
|
|
|
|
|
30.05.25 - 12:33
|
Cresco Labs Continues Track Record of Delivering Strong Operating Cash Flow (Business Wire)
|
|
|
Q1 operating cashflow of $30 millionCHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the first quarter ended and year ended March 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here.
First Quarter 2025 Highlights
First quarter revenue of $166 million. First quarter operating cash flow of $30 million and Free Cash Flow1 of $25 million.
Gross profit of $79 million. Adjusted gross profit1 of $82 million; and an Adjusted gross margin1 of 49% of revenue.
SG&A of $58 million or 35% of revenue.
Net loss of $15 million.
First quarter Adjusted EBITDA1 of $36 million and Adjusted EBITDA margin1...
|
|
|
29.05.25 - 12:33
|
Cresco Labs Announces Updated First Quarter 2025 Earnings Date (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), announced today that it will file its first quarter interim financial statements and MD&A on Friday, May 30, 2025.
Over the past three weeks, the Company has worked closely with its independent auditors to complete their review of the financial statements. The Company is pleased to report that the review was completed with no material changes from what was prepared for presentation on May 9th and looks forward to hosting a conference call and webcast to discuss its financial results.
Event: Cresco Labs First Quarter 2025 Earnings Conference Call
Date: Monday, June 2, 2025
Time: 8:30 am ET
Webcast: LINKConference Call Registration: LINKDial-in: 1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)
Access Code: 671160
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and profess...
|
|
|
|
|
08.05.25 - 23:03
|
Cresco Labs Announces Rescheduling of First Quarter 2025 Earnings Release and Conference Call (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”) today announced that the earnings call originally scheduled for May 9, 2025 will be postponed to provide additional time to complete procedures for the review of its first quarter interim financial statements. The Company will announce the rescheduled earnings call date once it has been determined but expects to host the earnings call and file its first quarter interim financial statements on or before the required filing date of May 30, 2025.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco,...
|
|
|
29.04.25 - 12:36
|
Cresco Labs to Report First Quarter 2025 Financial Results on May 9, 2025 (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the first quarter ended March 31st, 2025 on Friday, May 9, 2025 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs First Quarter 2025 Earnings Conference Call
Date: Friday, May 9, 2025
Time: 8:30 am ET
Webcast: LINKConference Call Registration: LINKDial-in: 1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)
Access Code: 671160
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG approach to building n...
|
|
|
|
|
|
|
|
|
12.03.25 - 12:03
|
Cresco Labs′ Disciplined Strategy Drives Record Cash Flow in 2024 Financial Results (Business Wire)
|
|
|
Record full year operating cashflow of $132 million, an increase of 126% from the prior year period
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter and year ended December 31, 2024. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here.
Fiscal Year 2024 Highlights
Revenue of $724 million. Record operating cash flow of $132 million and Free Cash Flow1 of $114 million.
Gross profit of $364 million. Adjusted gross profit1 of $374 million; and an Adjusted gross margin1 of 52% of revenue, a 270 bps improvement year-over-year.
SG&A of $221 million. Reduced Adjusted SG&A1 by 12% year...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
